Meanwhile, in contrast to TRAIL protein therapy, TRAIL-based gene therapy can potentially overcome the limitations of TRAIL by delivering TRAIL encoding DNA specifically to tumor cells and promoting the expression and secretion this therapeutic protein into the tumor microenvironment (Kagawa et al., 2001; Luo et al., 2016). The gene discussed is TNFSF10; the disease is neoplasm.